Schedule 13D ownership disclosure

VeraDermics, Inc.

Common Stock, par value $0.00001 · CUSIP: 922967104

Event date: 2026-02-05

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • SUVRETTA CAPITAL MANAGEMENT, LLCReported CIK 0001569064

    Shares: 4,168,991 · Class: 11.9%

  • Averill Master Fund, Ltd.Reported CIK 0001939329

    Shares: 3,648,538 · Class: 10.4%

  • Averill Madison Master Fund, Ltd.Reported CIK 0002021243

    Shares: 520,453 · Class: 1.5%

  • Aaron CowenReported CIK 0001869640

    Shares: 4,168,991 · Class: 11.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-26-000173
Form type
SCHEDULE 13D
Filer
MONTANOVA CAPITAL, LLC
CIK
CIK 1569064
Filed
Feb 11, 2026
Reporting period
Feb 05, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub